Has Saurin Sanghvi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,687 in general payments to Saurin Sanghvi, MD across 128 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Saurin Sanghvi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Saurin Sanghvi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Saurin Sanghvi, MD

Otolaryngology · Mount Laurel, NJNPI 1134564115

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (54.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Intersect ENT, Inc. at 42.0% of the total. Reporting peaked in 2021 at $2,928 and has fallen 72.4% since, to $809 in 2025. Among otolaryngology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,687in general payments, 2019–2025

Across 128 payments — averaging $52.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intersect ENT, Inc.$3K
Aerin Medical Inc.$1K
Sanofi$617
GSK$465
Regeneron Healthcare Solutions, Inc.$214
Optinose US, Inc.$204
plus $925 from 17 others

What the payments were for

Travel & lodging$2,91744%
Food & beverage$3,67155%
Education$991%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intersect ENT, Inc.	9	$2,806
Aerin Medical Inc.	15	$1,456
Sanofi	23	$617
GSK	25	$465
Regeneron Healthcare Solutions, Inc.	7	$214
Optinose US, Inc.	14	$204
Medtronic(2 entities)	3	$197
Takeda Pharmaceuticals U.S.A., Inc.	7	$159
Sanofi-aventis U.S. LLC	1	$99
Stryker	2	$56
Acclarent, Inc	3	$52
Amgen	2	$49
Neurent Medical Limited	1	$48
Alk-abello, Inc	3	$43
ARS Pharmaceuticals Operations, Inc.	2	$37
Smith+Nephew	2	$37
BD	1	$30
Kaleo, Inc.	2	$29
Merck	2	$27
Exelixis Inc.	1	$18
Greer Laboratories, Inc.	1	$17
Olympus America Inc.	1	$14
Hikma Pharmaceuticals USA	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

PROPEL$2,577
SINUVA$2,466
VIVAER STYLUS$987
DUPIXENT$358
NUCALA$125
NUVENT$119

How this compares

$6,687 in reported general payments places this provider in the 95th percentile of 232 otolaryngology providers in New Jersey.

See all otolaryngology providers in New Jersey →

Medicare billing

Part B allowed, 2024

$337,436

Medicare patients

711

Services billed

2,028

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	12	$44,309
Fluticasone Propionate	291	$4,424
Azelastine Hcl	137	$4,360
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth	22	$4,075
Ipratropium Bromide	134	$3,477
Ofloxacin	47	$1,481
Famotidine	107	$1,361
Fluocinolone Acetonide Oil	31	$875
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	76	$570
Methylprednisolone	106	$548
Omeprazole	26	$405
Doxycycline Hyclate	28	$330
Levofloxacin	20	$116
Mupirocin	23	$100
Prednisone	59	$86

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Mount Laurel

Anthony CultraraMount Laurel$3K
Nishant ReddyEast Windsor$133K
Giant LinFlorham Park$25K
Samir ShahVoorhees$16K
Brian BensonHackensack$14K
Andrew BlitzerHackensack$9K
Ahmad MahmoudClifton$9K
Jean EloyNewark$8K
Ramtin KassirWayne$8K
Wayne HsuehNewark$7K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →